Back
abrdn Life Sciences Investors Vs. SPDR® S&P Pharmaceuticals ETF Industry Stock Comparison
Buy
55
HQL
abrdn Life Sciences Investors
Last Price:
13.81
Seasonality Move:
0.43%
Sell
50
XPH
SPDR® S&P Pharmaceuticals ETF
Last Price:
39.86
Seasonality Move:
2.62%
Buy
55
abrdn Life Sciences Investors (HQL)
is a Buy
Is abrdn Life Sciences Investors a Buy, Sell or Hold?
- The current abrdn Life Sciences Investors [HQL] share price is $13.82. The Score for HQL is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- HQL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
SPDR® S&P Pharmaceuticals ETF (XPH)
is a Sell
Is SPDR® S&P Pharmaceuticals ETF a Buy, Sell or Hold?
- The current SPDR® S&P Pharmaceuticals ETF [XPH] share price is $39.85. The Score for XPH is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- XPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HQL Stock Price Chart
What is abrdn Life Sciences Investors's stock price today?
-
The abrdn Life Sciences Investors share price today is $13.82
The current trend is moderately bullish and HQL is experiencing selling pressure, which indicates risk of future bearish movement.
XPH Stock Price Chart
What is SPDR® S&P Pharmaceuticals ETF's stock price today?
-
The SPDR® S&P Pharmaceuticals ETF share price today is $39.85
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XPH is experiencing slight selling pressure.
HQL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.07 | Buy |
| Relative Strength Index (14 RSI): | 56.59 | Buy |
| Chaikin Money Flow: | -50621 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.4 - 14.06) | Buy |
| Bollinger Bands (100): | (13.24 - 13.96) | Buy |
XPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Sell |
| Relative Strength Index (14 RSI): | 37.64 | Sell |
| Chaikin Money Flow: | -2648 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.26 - 41.1) | Sell |
| Bollinger Bands (100): | (40.22 - 43.58) | Sell |
HQL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.8 | Buy |
| 20-day SMA: | 13.65 | Buy |
| 50-day SMA: | 13.46 | Buy |
| 200-day SMA: | 13.13 | Buy |
| 8-day EMA: | 13.77 | Buy |
| 20-day EMA: | 13.68 | Buy |
| 50-day EMA: | 13.59 | Buy |
| 200-day EMA: | 13.45 | Buy |
XPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0 | Buy |
| 20-day SMA: | 0 | Buy |
| 50-day SMA: | 0 | Buy |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 0 | Buy |
| 20-day EMA: | 0 | Buy |
| 50-day EMA: | 0 | Buy |
| 200-day EMA: | 0 | Buy |
abrdn Life Sciences Investors Earnings Growth & HQL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
SPDR® S&P Pharmaceuticals ETF Earnings Growth & XPH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
abrdn Life Sciences Investors Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
SPDR® S&P Pharmaceuticals ETF Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||